stugeron 15 mg tablets
jntl consumer health i (ireland) limited - cinnarizine - tablet - antivertigo preparations; cinnarizine
benylin non-drowsy dry coughs, syrup; dextromethorphan hydrobromide 7.5mg/5ml
jntl consumer health i (ireland) limited block 5, high street, tallaght, dublin 24, , ireland - syrup - dextromethorphan hydrobromide 7.5 mg/5ml - cough and cold preparations
imodium 2 mg capsules
johnson & johnson (ireland) limited - loperamide hydrochloride - capsule, hard - 2 milligram(s) - antipropulsives; loperamide
aegis daily facial spf 25- avobenzone, homosalate, octinoxate, octisalate, and octocrylene lotion
jntlee inc. dba panacea - avobenzone, 2.9% homosalate, 9.0% octinoxate, 6.8% octisalate, 4.5% octocrylene 5.0% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun
nicorette 16hr invisipatch
jntl consumer health (new zealand) limited - nicotine 15.75mg (delivery 10 mg nicotine over 16 hrs) - transdermal patch - 10mg/16 hours (size 9sq.cms) - active: nicotine 15.75mg (delivery 10 mg nicotine over 16 hrs) excipient: acrylic adhesive aluminium acetylacetonate butyl/isobutyl methacrylate copolymer carmellose sodium medium-chain triglycerides potassium hydroxide - the treatment of nicotine dependence, and the relief of withdrawal symptoms associated with smoking cessation. in smokers who are not prepared to stop immediately the patch may also be used in a preparation phase to reduce the need to smoke prior to stopping smoking completely.
nicorette 16hr invisipatch
jntl consumer health (new zealand) limited - nicotine 23.62mg (delivery 15 mg nicotine over 16 hrs.) - transdermal patch - 15mg/16 hours (size 13.5sq.cms) - active: nicotine 23.62mg (delivery 15 mg nicotine over 16 hrs.) excipient: acrylic adhesive aluminium acetylacetonate butyl/isobutyl methacrylate copolymer carmellose sodium medium-chain triglycerides potassium hydroxide - the treatment of nicotine dependence, and the relief of withdrawal symptoms associated with smoking cessation. in smokers who are not prepared to stop immediately the patch may also be used in a preparation phase to reduce the need to smoke prior to stopping smoking completely.
nicorette 16hr invisipatch
jntl consumer health (new zealand) limited - nicotine 39.37mg (delivery 25 mg over 16 hrs.) - transdermal patch - 25mg/16 hours (size 22.5sq.cms) - active: nicotine 39.37mg (delivery 25 mg over 16 hrs.) excipient: acrylic adhesive aluminium acetylacetonate butyl/isobutyl methacrylate copolymer carmellose sodium medium-chain triglycerides potassium hydroxide - the treatment of nicotine dependence, and the relief of withdrawal symptoms associated with smoking cessation. in smokers who are not prepared to stop immediately the patch may also be used in a preparation phase to reduce the need to smoke prior to stopping smoking completely.
nicorette cooldrops
jntl consumer health (new zealand) limited - nicotine polacrilex 10mg equivalent to 2 mg nicotine (plus 5% overage); - lozenge - 2 mg - active: nicotine polacrilex 10mg equivalent to 2 mg nicotine (plus 5% overage) excipient: acesulfame potassium hypromellose magnesium stearate mannitol polysorbate 80 purified water sepifilm gloss sodium carbonate sucralose titanium dioxide winterfresh flavour rde4-149 0488110 xanthan gum - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms.
nicorette cooldrops
jntl consumer health (new zealand) limited - nicotine polacrilex 20mg equivalent to 4 mg nicotine (plus 5% overage); - lozenge - 4 mg - active: nicotine polacrilex 20mg equivalent to 4 mg nicotine (plus 5% overage) excipient: acesulfame potassium hypromellose magnesium stearate mannitol polysorbate 80 purified water sepifilm gloss sodium carbonate sucralose titanium dioxide winterfresh flavour rde4-149 0488110 xanthan gum - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms.
nicorette freshfruit gum
jntl consumer health (new zealand) limited - nicotine polacrilex 10mg equivalent to 2 mg nicotine; ; - chewing gum - 2 mg - active: nicotine polacrilex 10mg equivalent to 2 mg nicotine excipient: acacia acesulfame potassium cafosa 258 soft carnauba wax hypromellose levomenthol light magnesium oxide nitrogen peppermint oil polysorbate 80 purified talc purified water sodium bicarbonate sodium carbonate sucralose titanium dioxide tutti fruitti flavour ql84441 xylitol - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.